Inventor · Foster City, CA, US

Ryan McFadden

22Patents
6h-index
66Co-inventors
68Inventor score

Filing activity: Dec 7, 2009 → Dec 21, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8367670B2 Modulators of toll-like receptors Emerging Cross-Sectional Technologies 29 Active
US9127006B2 Modulators of toll-like receptors Emerging Cross-Sectional Technologies 24 Active
US8629142B2 Modulators of toll-like receptors Emerging Cross-Sectional Technologies 14 Active
US8809527B2 Modulators of toll-like receptors Emerging Cross-Sectional Technologies 11 Active
US9452166B2 Modulators of toll-like receptors Emerging Cross-Sectional Technologies 10 Active
US10172860B2 Modulators of toll-like receptors Emerging Cross-Sectional Technologies 8 Active
US9284323B2 Naphthalene acetic acid derivatives against HIV infection Chemistry; Metallurgy 6 Active
US9573952B2 Methods of preparing toll-like receptor modulators Chemistry; Metallurgy 5 Active
US10774053B2 HIV protease inhibitors Human Necessities 4 Active
US9102614B2 Naphth-2-ylacetic acid derivatives to treat AIDS Chemistry; Metallurgy 3 Active
US11352329B2 HIV protease inhibitors Human Necessities 3 Active
US8987250B2 Therapeutic compounds Chemistry; Metallurgy 3 Active
US9006229B2 Benzothiazole compounds and their pharmaceutical use Chemistry; Metallurgy 2 Active
US9376392B2 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS Chemistry; Metallurgy 1 Active
US9464096B2 Therapeutic compounds Chemistry; Metallurgy 1 Active
US11878965B2 Inhibitors of peptidylarginine deiminases Chemistry; Metallurgy 1 Active
US11110091B2 Modulators of toll-like receptors Emerging Cross-Sectional Technologies 1 Active
US9096586B2 Therapeutic compounds Chemistry; Metallurgy 1 Active
US9879023B2 Therapeutic compounds Chemistry; Metallurgy 1 Active
US11179397B2 Imidazopyrimidine derivatives Chemistry; Metallurgy 0 Active
US10800772B2 Therapeutic compounds Chemistry; Metallurgy 0 Active
US8653307B2 Liphagal enantiomers and their derivatives and precursors, and enantioselective methods of making the same Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.